National Cancer Institute Drug Information System (NCI DIS)
Owner/Developer: National Cancer Institute (NCI)
|Country:||United States of America|
Since 1955, the National Cancer Institute has conducted extensive testing of materials for possible activity against different forms of cancer. Over 400,000 compounds have been aquired and the information management problems associated with this effort are best handled by a computer system. The NCI Drug Information System ( DIS ) was set up in 1980 in order to keep track of acquisition, storage, shipping, and testing of drugs at the National Cancer Institute. The DIS consists of 2 major sub-systems: The Pre-Registry and the Drug sub-systems. The Pre-Registry sub-system handles compound acquisition and only is of interest to those directly involved in the acquisition process.
|User access:||Open access - Free access|
|Updating frequency:||Infrequently updated|
|Purpose:||Documentation and information|
|Technology/Tools:||Non-testing methods (in silico)|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.